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Résumé en
anglais
BACKGROUND AND PURPOSE: The frequency of pain and cramps is uncertain in
anti-myelin associated glycoprotein antibody (anti-MAG) neuropathy. Whether these
symptoms may affect function/quality of life is unknown.
METHODS: A cross-sectional study of the prevalence, correlates and impact of pain,
pain subtypes and cramps, their severity, frequency and anatomical distribution was
performed for 55 clinically stable patients with anti-MAG neuropathy.
RESULTS: Pain of any type was reported by 80% of subjects. The most common
subtype was paraesthesiae and dysaesthesiae (70%). Cramps were reported by
>60% of patients, with lower limb cramps in all and upper limb cramps in about
20%. Cramps affected daily activities in >30% of these subjects, sleep in 60%, ability
to exercise in >30%. Total pain score correlated with several Short Form 36 health-
related quality of life (SF-36 HR-QoL) measures (P < 0.05), with Inflammatory
Rasch-built Overall Disability Scale (I-RODS) (P = 0.006) and 10-m timed walk
(P = 0.019). An independent association was ascertained with I-RODS (P = 0.002).
Different pain subtypes showed multiple associations with SF-36 HR-QoL measures
and/or functional scales. Upper limb cramps had multiple SF-36 HR-QoL functional
correlates, with an independent association with the Overall Neuropathy Limitation
Score (ONLS) (P = 0.004). Cramp severity correlated with ONLS (P = 0.04) and I-
RODS (P = 0.028) and inversely with level of physiotherapy input (P = 0.009).
Cramp frequency was associated with tremor score (P = 0.004) and multiple SF-36
HR-QoL subsections.
CONCLUSIONS: Neuropathic pain and cramps may affect function and quality of life
in anti-MAG neuropathy. Optimizing treatments of these symptoms, including by







Titre abrégé Eur. J. Neurol.
Identifiant




























Publié sur Okina (http://okina.univ-angers.fr)
